Antidote.me: Funding, Investors & Team (Oct 2026)
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
Antidote.me has raised $23.2M across 1 funding round on record, the most recent an undisclosed round of $23.2M announced in Jun 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Antidote.me Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Antidote.me Funding Rounds
Antidote.me Founders and Leadership Team
Contact details for the Antidote.me team: 1 of 1 has an email address on file.
Start 14-day free trial →Antidote.me Funding Compared to Other Biotechnology Startups
Antidote.me's latest round of $23.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Antidote.me in Biotechnology and London
Companies Similar to Antidote.me
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Antidote.me Funding FAQs
What does Antidote.me do?
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
How much funding has Antidote.me raised?
Antidote.me has raised $23.2M across 1 round on record. The most recent is an undisclosed round of $23.2M announced in Jun 2021.
When did Antidote.me last raise funding?
Antidote.me's most recent funding round on record is an undisclosed round of $23.2M, announced in Jun 2021.
Who is the CEO of Antidote.me?
Laurent Schockmel is listed as CEO at Antidote.me.
Where is Antidote.me headquartered?
Antidote.me is based in London, England, United Kingdom.
How many employees does Antidote.me have?
Antidote.me is in the 51-100 employee band.
How does Antidote.me's funding compare to other Biotechnology startups?
Antidote.me's latest round of $23.2M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Antidote.me Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Antidote.me is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.